Hangzhou Fuluo Biological Technology Co.,Ltd.

 

Whatsapp:+8613336060458

Emial:jennysteroidsraw@protonmail.com

 

        

Home
Products
About Us
Factory Tour
Quality Control
Contact Us
Request A Quote
Home ProductsNootropic Powder

99% Raw Nootropic Powder NSI-189 , Smart drug NSI-189 White Powder 1270138-40-3

Good quality Testosterone Steroids for sales
Good quality Testosterone Steroids for sales
The Anavar suspended way better than it usual doed for me.Those could be postitive things.I'm Just making sure.

—— Jason

Your product help me put on nice clean gains no water retention or unwanted fat

—— Leo

Hey Nancy, Sorry for not replying,Ive been in the hospital for some time.I had some testers use both yohimbine and cialis which they said worked exce

—— Gordon

Thanks for understanding.i had to tell your competitors to go away.I only buy from you.in loyal.you've all been very good to me.I'll need 200g of test

—— Jordan

thanks for your continued great service. Jordy

—— Jordy

Hi Nancy! Just did HPLC test on RAD 140 now: Very happy here

—— Francois

I'm Online Chat Now

99% Raw Nootropic Powder NSI-189 , Smart drug NSI-189 White Powder 1270138-40-3

China 99% Raw Nootropic Powder NSI-189 , Smart drug NSI-189 White Powder 1270138-40-3 supplier
99% Raw Nootropic Powder NSI-189 , Smart drug NSI-189 White Powder 1270138-40-3 supplier 99% Raw Nootropic Powder NSI-189 , Smart drug NSI-189 White Powder 1270138-40-3 supplier

Large Image :  99% Raw Nootropic Powder NSI-189 , Smart drug NSI-189 White Powder 1270138-40-3

Product Details:

Place of Origin: Wuhan,Hubei
Brand Name: Yuancheng
Certification: ISO9001
Model Number: 1270138-40-3

Payment & Shipping Terms:

Minimum Order Quantity: 10g
Price: Negotiatable
Packaging Details: Discreet packaging
Delivery Time: 4-7 working days
Payment Terms: T/T, Western Union, MoneyGram,bitcoin
Supply Ability: 5000kg/Month
Contact Now
Detailed Product Description
Name: NSI-189 CAS No: 1270138-40-3
Molecular Formula: C22H30N4O Formula Weight: 366.4998
Appearance: Off-white Powder Purity: 99%

99% Raw Nootropic Powder NSI-189,Smart drug NSI-189 White Powder

NSI-189
Other Names:NSI-189 Phosphate, (4-benzylpiperazin-1-yl)-[2-(3-methylbutylamino)pyridin-3-yl]methanone
Molecular Formula:C22H30N4O
Formula Weight:366.4998
CAS No.:1270138-40-3
Appearance:off-white powder
Purity:99%

 

NSI-189 Background:
NSI-189 is a benzylphiperizine-aminiopyridine, nootropic and neurogenic research chemical created by Neuralstem, Inc. that was derived from pyrazine and nicotinamide. Studies have shown that it stimulates neurogenesis of human hippocampus-derived neural stem cells in vivo and vitro . In healthy adult mice, NSI-189 has been shown to increase the hippocampal volume by 20% and reverse behavioral symptoms in mouse depression models, meaning at the source it could address depression . The hippocampus is responsible for spatial navigation, along with the consolidation of information from short-term memory to long-term memory.

 

The chemical entity stimulates new neuron growth in the hippocampus, which is an area of the brain that is believed to be contributory in conditions such as post-traumatic stress disorder (PTSD), Alzheimer’s disease, and major depressive disorder (MDD).

 

NSI-189’s Method of Action:
Although it has been demonstrated in rats and chimps, the suggestion that having too small of a hippocampus causes depression and other diseases in humans is still technically just a theory. NSI-189 increases hippocampal volume in adult mice by 20%, a region of the brain that is one of the first to suffer damage resulting in memory loss, disorientation, encephalitis, and hypoxia from disease’s such as Alzheimer’s .

 

NSI-189 Benefits:
Tests have shown that NSI-189 significantly improved behavioral responses that are associated with depression . In humans it may counter hippocampal atrophy which is seen in disorders such as MDD, reversing their symptoms. A phase 1B randomized, double-blind, placebo-controlled, multiple-dose escalation study conducted over a 28 day period showed behavioral efficacy in 24 patients who were orally administered NSI-189 . The efficacy measurements showed a clinically meaningful reduction in cognitive and depressive symptoms across all measures, and appeared to persist over time during follow up for the efficacy assessments which included the Clinical Global Impression - Improvement (CGI-I), Montgomery-Aserb Depression Rating Scale (MADRS), Cognitive and Physical Functioning Questionnaire (CPFQ, and the Symptoms of Depression Questionnaire (SDQ) .

 

Dosing NSI-189:
Phase 1A tested escalating doses of the neurogenic compound NSI-189 in healthy patients, 1B tested the safety of escalating doses in 24 depressed patients over the course of 28 days . During phase 1B patients were administered 40 mg per day, and 80 mg per day, and at the highest dose 120 mg per day. No serious adverse events occurred during the time of the study and the drug was well tolerated. Reduction in cognitive and depressive symptoms were observed across all measures for the two lower doses 40 mg/day and 80 mg/day but not for the highest dose 120 mg/day .

 

Other information:
The main limitations of the phase 1B study was the small sample size of each cohort, and also the fact that efficacy analyses were not the primary focus. In summary, NSI-189 looks promising as a potential treatment for MDD in a Phase 1B, double-blind, randomized, placebo-controlled, multiple-dose study with three ascending cohorts.

 

The preliminary findings are supportive of the view that neurogenesis-based platforms are capable of identifying auspicious new treatments for MDD. However, further studies are imperative to confirm the preliminary observations. Neuralstem intends to pursue further clinical trials for various encephalopathic conditions including post-traumatic stress disorder, traumatic brain injury, and natural aging.

 

The COA of NSI-189:

 

 

Product name

 

 

NSI-189

CAS No.

 

1270138-40-3

Outer Packing

 

 

Production date

 

Dec. 15. 2016.

Shelf life

 

Dec. 14th. 2019

Standard adopted

 

 

in-house standard

Items of analysis Specification Results

 

 

Appearance

 

 

Off-white powder

 

 

Confrom

 

 

Identification

 

 

IR and HPLC spectrum shall conform to the standard sample

 

 

conform

 

 

Melting Point

 

 

83℃~86℃

 

 

84.3℃~85.6℃

 

 

Loss on Drying

 

 

Less than 0.5%

 

 

0.29%

 

 

Purity(On Dried Base,HPLC)

 

 

NLT 99.5 %

 

 

99.62%

 

 

Total Impurity

 

 

Less than 0.5%

 

 

0.33%

 

 

Residue On Ignition

 

 

≤0.2%

 

 

0.16%

 

 

Heavy metal

 

 

≤20ppm

 

 

conform

Conclusion Qualified

 

99% Raw Nootropic Powder NSI-189 , Smart drug NSI-189 White Powder 1270138-40-3

 

Contact Details
Hangzhou Fuluo Biological Technology Co.,Ltd.

Contact Person: Nancy

Send your inquiry directly to us (0 / 3000)